Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,500 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $10,500 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $2,800 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($2,800) |
| 2017 | $7,700 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($7,700) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/15/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | EXJADE (Drug) | — | Cash or cash equivalent | $2,800.00 | Research |
| Study: A MULTI CENTER RANDOMIZED DOUBLE BLIND PLACEBOCONTROLLED CLINICAL TRIAL OF DEFERASIROX IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES LOW INT1 RISK AND TRANSFUSIONAL IRON OVERLOAD TELESTO • Category: HEMATOLOGY | ||||||
| 01/03/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | EXJADE (Drug) | — | Cash or cash equivalent | $7,700.00 | Research |
| Study: A MULTI CENTER RANDOMIZED DOUBLE BLIND PLACEBOCONTROLLED CLINICAL TRIAL OF DEFERASIROX IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES LOW INT1 RISK AND TRANSFUSIONAL IRON OVERLOAD TELESTO • Category: HEMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTI CENTER RANDOMIZED DOUBLE BLIND PLACEBOCONTROLLED CLINICAL TRIAL OF DEFERASIROX IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES LOW INT1 RISK AND TRANSFUSIONAL IRON OVERLOAD TELESTO | NOVARTIS PHARMACEUTICALS CORPORATION | $10,500 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,276 | 1,339 | $448,163 | $84,580 |
| 2022 | 15 | 1,398 | 1,506 | $490,606 | $92,901 |
| 2021 | 17 | 1,341 | 1,447 | $478,205 | $93,353 |
| 2020 | 14 | 1,185 | 1,382 | $432,666 | $88,849 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 529 | 534 | $152,598 | $28,730 | 18.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 160 | 160 | $110,897 | $19,714 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 76 | $41,282 | $7,961 | 19.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 96 | $28,520 | $6,431 | 22.5% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 35 | 35 | $32,423 | $6,373 | 19.7% |
| 93314 | Interpretation and report of ultrasound of heart | Facility | 2023 | 57 | 58 | $22,968 | $4,297 | 18.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $21,735 | $3,965 | 18.2% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 19 | 19 | $13,537 | $2,772 | 20.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 77 | 78 | $7,236 | $970.10 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $4,632 | $913.86 | 19.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 52 | 53 | $3,881 | $791.29 | 20.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 29 | 29 | $2,987 | $585.48 | 19.6% |
| 93319 | 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | Facility | 2023 | 19 | 19 | $1,926 | $384.37 | 20.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 43 | 43 | $1,258 | $251.58 | 20.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 26 | 26 | $1,264 | $251.42 | 19.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 74 | 74 | $1,019 | $188.34 | 18.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 591 | 595 | $176,428 | $32,620 | 18.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 149 | 150 | $107,976 | $18,195 | 16.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 59 | $46,903 | $9,973 | 21.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 160 | $45,770 | $9,718 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 63 | $33,630 | $6,856 | 20.4% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2022 | 32 | 32 | $29,089 | $6,135 | 21.1% |
| 93314 | Interpretation and report of ultrasound of heart | Facility | 2022 | 52 | 52 | $20,592 | $3,963 | 19.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 13 | 13 | $5,601 | $1,118 | 20.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 48 | 49 | $4,951 | $1,034 | 20.9% |
About Dr. Danita Sanborn, MD
Dr. Danita Sanborn, MD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770574071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danita Sanborn, MD has received a total of $10,500 in payments from pharmaceutical and medical device companies, with $2,800 received in 2018. These payments were reported across 2 transactions from 1 company. The most common payment nature is "" ($10,500).
As a Medicare-enrolled provider, Sanborn has provided services to 5,200 Medicare beneficiaries, totaling 5,674 services with total Medicare billing of $359,683. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Boston, MA
- Active Since 11/04/2005
- Last Updated 04/08/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770574071
Products in Payments
- EXJADE (Drug) $10,500
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M